netFormulary Leicestershire Health Community NHS
Medicines Formulary  
 Search
 Formulary Chapter 6: Endocrine system - Full Chapter
06.01.01.02  Expand sub section  Intermediate- and long-acting insulins
06.01.01.02  Expand sub section  Biphasic insulins
06.01.01.02  Expand sub section  Intermediate Acting Insulin
06.01.01.02  Expand sub section  Long Acting Insulin Analogues
Abasaglar®
View adult BNF View SPC online  Track Changes
Formulary
Green
A Biosimilar of Insulin Glargine.
MUST BE PRESCRIBED BY BRAND NAME
Recommended in LLR for new patients and those undergoing review of therapy. 
Link  Statement on Use of Biosimilar Insulin
   
Lantus®
View adult BNF View SPC online  Track Changes
Formulary
Green
Insulin Glargine 100 unit per ml
MUST BE PRESCRIBED BY BRAND NAME
Recombinant human insulin analogue- long acting. Monophasic. Once daily dosage

Vial, Cartridge+ClikSTAR, SoloStar 
   
Levemir®
View adult BNF View SPC online
Formulary
Green
Insulin Detemir.
Recombinant human insulin analogue – long acting. Monophasic. Twice daily dosing
Cartridge + NovoPen 4, Flexpen
Innolet also available but only for patients not able to manage less expensive device 
   
Toujeo®
View adult BNF View SPC online  Track Changes
Formulary
Green

Insulin Glargine 300 units per ml.
MUST BE PRESCRIBED BY BRAND NAME
First line concentrated insulin of choice in insulin resistant patients requiring large amounts of insulin. Please take extra care in prescribing, insulin glargine 300units per ml and 100units per ml are not directly interchangeable - see SPC

 
Link  Leicestershire Evaluation: Toujeo® in Diabetes
Link  UKMI - Product Safety Assessment Report
   
Tresiba®
View adult BNF View SPC online  Track Changes
Formulary
Green

Insulin Degludec
For use in specific patient groups only in line with agreed algorithm.

  • Conditional Green traffic light status for GPs who have completed appropriate training.
  • Amber traffic light status for those without additional training.
 
Link  Leicestershire Evaluation: Insulin Degludec in Diabetes
Link  Tresiba (Insulin Degludec) 100 units per ml: patient selection criteria
Link  Tresiba (Insulin Degludec) 200 units per ml: patient selectin criteria
   
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Black

Drugs not recommended for use in the Leicestershire Health Community because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety. All new drugs will be black until they have been through the appropriate approval process - then they will appear as a specific entry   

Red

Drugs which should be prescribed only by hospital specialists (clinical review by specialist as appropriate and annually as a minimum).  

Amber SCA

Drugs which would initially be prescribed by a hospital specialist and then by a GP where full agreement to share the care of each specific patient has been reached under a LMSG Shared Care Agreement (SCA). Specific patient monitoring or intervention required.   

Amber Simple

Drugs suitable to be initiated and prescribed in primary care only after specialist assessment and recommendation. A shared care agreement is not required.   

Green

Drugs for which GPs would normally take full responsibility for prescribing and monitoring. Drugs included in this list have been specifically considered by LMSG.   

Grey

Drugs not yet reviewed  

Green Conditional

Drugs for which GPs are able to take full responsibility for prescribing and monitoring subject to specified conditions e.g. prescribing in line with agreed LMSG guidance or able to demonstrate suitable competence. See comments under individual entries  

netFormulary